IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Soleno Therapeutics Inc

CUSIP: 834203200 | 129 institutional holders

Quarters

Q2 2024Q1 2024Q3 2022Q2 2022Q1 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

TCG Crossover Management, LLC550,000
2.3% of portfolio›$22.4M
StyleTurnoverLocationFiled
TCG Crossover Management, LLC
550,000$22.4M2.3%GrowthMediumPalo Alto, CA2024-08-14